Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene

Virology

Volumn 248, Issue 2, 1998, Pages 332-341

  Coscoy, Laurent ^a   Gonzalez Dunia, Daniel ^a   Tangy, Frédéric ^a   Syan, Sylvie ^a   Brahic, Michel ^a   Ozden, Simona ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; DEGENERATIVE DISEASE; HUMAN T CELL LEUKEMIA VIRUS; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; VIRUS INFECTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MUS MUSCULUS; RNA VIRUSES; RODENTIA;

EID: 0032169913     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9298     Document Type: Article

References (50)

1. Ballard D., Böehnlein E., Lowenthal W., Wano Y., Franza B., Greene W. HTLV-I Tax induces cellular proteins that activates the KB element in the IL2 receptor a gene. Science. 241:1988;1652-1655.
2. Bantignies F., Rousset R., Desbois C., Jalinot P. Genetic characterization of transactivation of the HTLV-I promoter: binding of Tax to Tax responsive element I is mediated by the cyclic AMP-responsive members of the CREB/ATF family of transcription factors. Mol. Cell. Biol. 16:1996;2174-2182.
3. Baranger A., Palmer C., Hamm M., Giebler H., Brauweiler A., Nyborg J., Schepartz A. Mechanism of DNA binding enhancement by HTLV-I transactivator Tax. Nature. 376:1995;606-608.
4. Bèraud C., Sun S., Ganchi P., Ballard D., Greene W. HTLV-I Tax associates with and is regulated by NF-κB2 p 100 gene product: implications for viral latency. Mol. Cell. Biol. 14:1994;1374-1382.
5. Brahic, M. Ozden, S. 1992, Simultaneous detection of cellular RNA and proteins, In, In Situ Hybridization: A Practical Approach, 85, 104, IRL Press, Oxford.
6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
7. Coscoy L., Gonzalez-Dunia D., Chirinian-Syan S., Brahic M., Ozden S. Analysis of the expression directed by two HTLV-I promoters in transgenic mice. J. Neurovirol. 2:1996;336-344.
8. Cosset F., Takeuchi Y., Battini J., Weiss R., Collins M. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:1995;7430-7436.
9. Evangelista A., Maroushek S., Minnigan H., Larson A., Retzel E., Haase A. T., Gonzalez-Dunia D., McFarlin D., Mingioli E., Jacobson S., Osame M., Sonoda S. Nucleotide sequence analysis of a provirus derived from an individual with tropical spastic paraparesis. Microb. Pathogen. 8:1990;259-278.
10. 1. Proc. Natl. Acad. Sci. USA. 85:1988;8526-8530.
11. Fujii M., Tsuchiya H., Toita M., Yoshida M. Interaction of HTLV-I Tax with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:1992;2066-2076.
12. Gessain A., Barin E., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
13. Gonzalez-Dunia D., Chirinian-Syan S., Brahic M., Ozden S. Functional analysis of two long terminal repeats from the HTLV-I retrovirus. Gene. 116:1992;151-158.
14. Gonzalez-Dunia D., Komurian-Pradel F., Chirinian-Syan S., de Thé G., Brahic M., Ozden S. Comparative analysis of HTLV-I promoter activities reveals no disease-linked pattern of expression. AIDS Res. Hum. Retroviruses. 9:1993;337-341.
15. Grassmann R., Dengler C., Muller-Fleckenstein I., Fleckenstein B., McGuire K., Dokhelar M., Sodorski J., Haseltine A. Transformation to continuous growth of primary T lymphocyte by HTLV-I X region genes transduced by a herpesvirus saimiri vector. Proc. Natl. Acad. Sci. USA. 92:1989;1057-1061.
16. Grossman W. J., Kimata J. T., Wong F.-H., Zutter M., Ley T. J., Ratner L. Development of leukemia in mice transgenic for thetax. Proc. Natl. Acad. Sci. USA. 92:1995;1057-1061.
17. Hinrichs S. H., Nerenberg M., Reynolds R. K., Khoury G., Jay G. A transgenic mouse model for human neurofibromatosis. Science. 237:1987;1340-1343.
18. Hinuma Y., Nagata K., Hanaoka M., Misoka M., Nakal T., Matsumoto T., Kinoshita K., Shirakawa S., Miyoshi I. Adult T cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA. 78:1981;6476-6480.
19. x. EMBO J. 5:1986;2883-2888.
20. Kanno T., Brown K., Franzoso G., Siebenlist U. Kinetic analysis of Human T cell leukemia virus type I Tax-mediated activation of NF-κB. Mol. Cell. Biol. 14:1994;6443-6451.
21. Kitajima I., Shinohara T., Bilakovics J., Brown D. A., Xu X., Nerenberg M. Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-κB. Science. 258:1992;1792-1795.
22. Lacoste J., Petropoulos L., Pepin L., Hiscott J. Constitutive phosphorylation and turnover of IKB in human T cell leukemia virus type I infected and Tax-expressing cells. J. Virol. 69:1995;564-569.
23. Matsumoto K., Shibata H., Fujisawa J., Inoue H., Hakura A., Tsukahara T., Fujii M. HTLV-I Tax protein transforms rat fibroblastes via two distinct pathways. J Virol. 71:1997;4445-4451.
24. Mochizuki M., Watanabe T., Yamaguchi K. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn. J. Cancer Res. 83:1992;236-239.
25. Morgan O., Rodgers-Johnson P., Mora C., Char G. HTLV-I and polymyositis in Jamaica. Lancet. 2:1989;1184-1186.
26. Munoz E., Courtois S., Veschambre P., Jalinot P., Israel A. Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκB alpha/MAD3. J. Virol. 68:1994;8035-8044.
27. Nerenberg M., Hinrichs S. H., Reynolds R. K., Khoury G., Jay G. The tat gene of human T lymphotropic virus type I induces mesenchymal tumors in transgenic mice. Science. 237:1987;1324-1329.
28. Nerenberg M. I., Minor T., Price J., Ernst D. N., Shinohara T, Schwarz H. Transgenic thymocytes are refractory to transformation by the human T cell leukemia virus type Itax. J. Virol. 65:1991;3349-3353.
29. Nishioka K., Maruyama I., Sato K., Kitajama I., Nakajima Y., Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1:1989;441.
30. Osame M., Usuku K., Izumo S., Ijichi N., Amitani H., Igata A., Matsumoto M., Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1:1986;1031-1032.
31. Ozden S., Aubert C., Gonzalez-Dunia D., Brahic M. In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection. J. Histochem. Cytochem. 39:1991;1305-1309.
32. Perini G., Wagner S., Green M. Recognition of bZIP proteins by the human T cell leukaemia virus transactivator Tax. Nature. 376:1995;602-605.
33. Poiesz B. J., Ruscetti F. W., Gadzar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
34. Pozzati R., Vogel J., Jay G. The HTLV-I tax gene can cooperate with the Ras oncogene to induce neoplastic transformation of cell. Mol. Cell. Biol. 10:1990;413-417.
35. Reid R., Lindholm P., Mireskandari A., Dittmer J., Brady J. Stabilization of wild-type P53 in human T lymphocytes transformed by HTLV-I. Oncogene. 8:1993;3029-3036.
36. Rousset R., Desbois C., Bantignies F., Jalinot P. Effect on NK-κB1/p105 processing of the interaction between HTLV-I transactivator Tax and the proteasome. Nature. 381:1996;328-331.
37. Saggioro D., Rosato A., Esposito G., Rosenberg M., Harrisson J., Felber B., Pavlakis G., Chieco-Bianchi L. Inflammatory polyarthropathy and bone remodeling in HTLV-I tax-transgenic mice. J. AIDS Hum. Retrovirol. 14:1997;272-280.
38. Smith M., Greene W. Type I human T cell leukemia virus Tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway. J. Clin. Invest. 88:1991;1038-1042.
39. Suzuki T., Kitao S., Matsushime H., Yoshida M. HTLV-I Tax protein interacts with cyclin-dependant kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. EMBO J. 15:1996;1607-1614.
40. Tanaka A., Takahashi C., Yamaoka S., Nosaka T., Maki M., Hatanaka M. Oncogenic transformation by the tax gene of HTLV-I in vitro. Proc. Natl. Acad. Sci. USA. 87:1990;1071-1075.
41. Terada K., Katamine S., Eguchi K., Moriuchi R., Kita M., Shimada H., Yamashita I., Iwata K., Tsuji Y., Nagataki S., Miyamoto T. Prevalence of serum and salivary antibodies to HTLV-I in Sjögren's syndrome. Lancet. 344:1994;1116-1119.
42. Vernant J. C., Buisson G., Magdeleine J., De Thore J., Jouannelle A., Neisson-Vernant C., Monplaisir N. T lymphocyte alveolitis, tropical spastic paraparesis, and Sjögren syndrome. Lancet. 1:1988;177.
43. Weil R., Laurent-Winters C., Israël A. Regulation of IκBβ degradation. J. Biol. Chem. 272:1997;9942-9949.
44. Xu X., Kang S., Heidenreich O., Da B., Nerenberg M. Sequence requirements of ATF2 and CREB binding to the HTLV-I LTR R region. Virology. 218:1996;362-371.
45. Yamaoka S., Inoue H., Sakurai M., Sugiyama T., Hazama M., Yamada T., Hatanaka M. Constitutive activation of NF-KB is essential for transformation of rat fibroblasts by tha HTLV-I Tax protein. EMBO J. 15:1996;873-887.
46. Yamato K., Oka T., Hiroi M., Iwahara Y., Sugito S., Tsuchida N., Miyoshi I. Aberrant expression of the P53 tumor suppressor gene in ATL and HTLV-I infected cells. Jpn. J. Cancer Res. 84:1993;4-8.
47. Yoshida B., Miyhoshi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T cell leukaemia and its implication in the disease. Proc. Natl. Acad. Sci. USA. 79:1982;2031-2035.
48. Yoshida M. Tax: regulation of gene expression and disease. Trends Microbiol. 1:1993;131-135.
49. Yoshida M. Multiple targets of HTLV-I for dysregulation of host cells. Semin. Virol. 7:1996;349-360.
50. Zhao L., Giam C. Interaction of HTLV-I transcriptional activator Tax with cellular factors that bind specifically to the 21 bp repeats in the HTLV-I enhancer. Proc. Natl. Acad. Sci. USA. 88:1991;11445-11449.